Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 2
2012 2
2013 4
2014 1
2015 3
2016 2
2017 7
2018 3
2019 11
2020 11
2021 17
2022 20
2023 19
2024 17
2025 19

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

124 results

Results by year

Filters applied: . Clear all
Page 1
La prise en charge des cancers médullaires de la thyroïde en 2024.
Lasolle H, Borson-Chazot F, Gauduchon T, Haissaguerre M, Illouz F, Lifante JC, Lussey-Lepoutre C, Prunier D, Sajous C, Varnier R, Hadoux J. Lasolle H, et al. Among authors: hadoux j. Bull Cancer. 2024 Oct;111(10S1):10S53-10S63. doi: 10.1016/S0007-4551(24)00408-9. Bull Cancer. 2024. PMID: 39505437 Review. French.
Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer.
Hadoux J, Elisei R, Brose MS, Hoff AO, Robinson BG, Gao M, Jarzab B, Isaev P, Kopeckova K, Wadsley J, Führer D, Keam B, Bardet S, Sherman EJ, Tahara M, Hu MI, Singh R, Lin Y, Soldatenkova V, Wright J, Lin B, Maeda P, Capdevila J, Wirth LJ; LIBRETTO-531 Trial Investigators. Hadoux J, et al. N Engl J Med. 2023 Nov 16;389(20):1851-1861. doi: 10.1056/NEJMoa2309719. Epub 2023 Oct 21. N Engl J Med. 2023. PMID: 37870969 Clinical Trial.
Sunitinib for metastatic progressive phaeochromocytomas and paragangliomas: results from FIRSTMAPPP, an academic, multicentre, international, randomised, placebo-controlled, double-blind, phase 2 trial.
Baudin E, Goichot B, Berruti A, Hadoux J, Moalla S, Laboureau S, Nölting S, de la Fouchardière C, Kienitz T, Deutschbein T, Zovato S, Amar L, Haissaguerre M, Timmers H, Niccoli P, Faggiano A, Angokai M, Lamartina L, Luca F, Cosentini D, Hahner S, Beuschlein F, Attard M, Texier M, Fassnacht M; ENDOCAN-COMETE; ENSAT Networks. Baudin E, et al. Among authors: hadoux j. Lancet. 2024 Mar 16;403(10431):1061-1070. doi: 10.1016/S0140-6736(23)02554-0. Epub 2024 Feb 22. Lancet. 2024. PMID: 38402886 Clinical Trial.
Durability of Response With Selpercatinib in Patients With RET-Activated Thyroid Cancer: Long-Term Safety and Efficacy From LIBRETTO-001.
Wirth LJ, Brose MS, Subbiah V, Worden F, Solomon B, Robinson B, Hadoux J, Tomasini P, Weiler D, Deschler-Baier B, Tan DSW, Maeda P, Lin Y, Singh R, Bayt T, Drilon A, Cassier PA. Wirth LJ, et al. Among authors: hadoux j. J Clin Oncol. 2024 Sep 20;42(27):3187-3195. doi: 10.1200/JCO.23.02503. Epub 2024 Aug 2. J Clin Oncol. 2024. PMID: 39094065 Free PMC article. Clinical Trial.
Anaplastic Thyroid Carcinoma: An Update.
Jannin A, Escande A, Al Ghuzlan A, Blanchard P, Hartl D, Chevalier B, Deschamps F, Lamartina L, Lacroix L, Dupuy C, Baudin E, Do Cao C, Hadoux J. Jannin A, et al. Among authors: hadoux j. Cancers (Basel). 2022 Feb 19;14(4):1061. doi: 10.3390/cancers14041061. Cancers (Basel). 2022. PMID: 35205809 Free PMC article. Review.
Strategies for Radioiodine Treatment: What's New.
Sparano C, Moog S, Hadoux J, Dupuy C, Al Ghuzlan A, Breuskin I, Guerlain J, Hartl D, Baudin E, Lamartina L. Sparano C, et al. Among authors: hadoux j. Cancers (Basel). 2022 Aug 4;14(15):3800. doi: 10.3390/cancers14153800. Cancers (Basel). 2022. PMID: 35954463 Free PMC article. Review.
[De-escalation strategies in differentiated thyroid cancer].
Hartl DM, Hadoux J, Garcia C, Ghuzlan AA, Guerlain J, Breuskin I, Baudin E, Lamartina L. Hartl DM, et al. Among authors: hadoux j. Bull Cancer. 2021 Dec;108(12):1132-1144. doi: 10.1016/j.bulcan.2021.07.008. Epub 2021 Oct 11. Bull Cancer. 2021. PMID: 34649722 Review. French.
French expert consensus statement on diagnosis and management of primary hyperparathyroidism.
Vantyghem MC, Mirallié E, Al-Salameh A, Aubert S, Barraud S, Baud G, Ben Hamou A, Bertocchio JP, Borson-Chazot F, Bouillet B, Briet C, Buffet C, Caiazzo R, Cardot-Bauters C, Cariou B, Chabre O, Chanson P, Charbit J, Chéreau N, Chevalier B, Cirenei C, Coppin L, Corvillain B, Christou N, Cuny T, Deandreis D, Deguelte S, Delemer B, Desailloud R, Do Cao C, Donatini G, Drui D, Dupeux M, Espiard S, Figueres L, Frey S, Ghanassia E, Ghander C, Gaujoux S, Goichot B, Groussin L, Gueorguieva I, Guérin C, Hadoux J, Haissaguerre M, Henry H, Hindié E, Houiller P, Jannin A, Kerlan V, Klein M, Koumakis E, Kuczma P, Ladsous M, Lasolle H, Le Bras M, Lecoq AL, Lemaitre M, Lifante JC, Linglart A, Lopez AG, Lussey-Lepoutre C, Luton D, Maione L, Marciniak C, Mathonnet M, Menegaux F, Molin A, Mosbah H, Nominé-Criqui C, Odou MF, Osman D, Paladino NC, Picart C, Romanet P, Santucci N, Scheyer N, Sebag F, Sokol E, Taieb D, Tauveron I, Tresallet C, Triponez F, Vergès B, Vezzosi D, Brunaud L, Kamenicky P. Vantyghem MC, et al. Among authors: hadoux j. Ann Endocrinol (Paris). 2025 Aug 30;86(5):102449. doi: 10.1016/j.ando.2025.102449. Online ahead of print. Ann Endocrinol (Paris). 2025. PMID: 40889554
124 results